Evidence map›Paper›PMID 24093092›Full record

ArticleBioMed research international2013

Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region.

Mbarka Bchetnia, Nadia Laroussi, Monia Youssef, Cherine Charfeddine, Ahlem Sabrine Ben Brick, Mohamed Samir Boubaker, Mourad Mokni, Sonia Abdelhak, Jameleddine Zili, Rym Benmously

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Atypical Mal de Meleda in a Hispanic Patient.Case reports in dermatological medicine · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. [Palmoplantar dermatoses: when should genes be considered?].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2014
    Review
  7. Two Sisters with Mal de Meleda: Case Series Report.International journal of applied & basic medical research
    Article
  8. Mal De Meleda with Flexural Involvement.Indian dermatology online journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Mbarka BchetniaUniversité de Tunis El Manar, Institut Pasteur de Tunis, Laboratoire de Génomique Biomédicale et Oncogénétique (LR11IPT05), BP74, 13 Place Pasteur, Belvédère, 1002 Tunis, Tunisia.
Nadia Laroussi
Monia Youssef
Cherine Charfeddine
Ahlem Sabrine Ben Brick
Mohamed Samir Boubaker
Mourad Mokni
Sonia Abdelhak
Jameleddine Zili
Rym Benmously
Tunis El Manar University · TNHôpital Farhat Hached · TNTunis University · TNHabib hospital Thameur · TNHôpital La Rabta · TNInstitut Pasteur de Tunis · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mal de Meleda (MDM) is a rare, autosomal recessive form of palmoplantar keratoderma. It is characterized by erythema and hyperkeratosis of the palms and soles that progressively extend to the dorsal surface of the hands and feet. It is caused by mutations in SLURP-1 gene encoding for secreted mammalian Ly-6/uPAR-related protein 1 (SLURP-1). We performed mutational analysis by direct sequencing of SLURP-1 gene in order to identify the genetic defect in three unrelated families (families MDM-12, MDM-13, and MDM-14) variably affected with transgressive palmoplantar keratoderma. A spectrum of clinical presentations with variable features has been observed from the pronounced to the transparent hyperkeratosis. We identified the 82delT frame shift mutation in the SLURP-1 gene in both families MDM-12 and MDM-13 and the missense variation p.Cys99Tyr in family MDM-14. To date, the 82delT variation is the most frequent cause of MDM in the world which is in favour of a recurrent molecular defect. The p.Cys99Tyr variation is only described in Tunisian families making evidence of founder effect mutation of likely Tunisian origin. Our patients presented with very severe to relatively mild phenotypes, including multiple keratolytic pits observed for one patient in the hyperkeratotic area which was not previously reported. The phenotypic variability may reflect the influence of additional factors on disease characteristics. This report further expands the spectrum of clinical phenotypes associated with mutations in SLURP1 in the Mediterranean population.

Indexed as

Founder EffectAntigens, LyDNA Mutational AnalysisFrameshift MutationHigh-Throughput Nucleotide SequencingHumansKeratoderma, PalmoplantarMediterranean RegionPedigreePhenotypeTunisiaUrokinase-Type Plasminogen ActivatorAntigens, LySLURP1 protein, humanUrokinase-Type Plasminogen Activator

Identifiers

PMID24093092
PMCPMC3777190
OpenAlexW2144122914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.